Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000236:Adenoma / Q000150:complications; D000293:Adolescent; D000307:Adrenal Gland Diseases / Q000150:complications; D000310:Adrenal Gland Neoplasms / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D000368:Aged; D001774:Blood Chemical Analysis; D002277:Carcinoma / Q000150:complications; D002986:Clinical Trials as Topic; D003480:Cushing Syndrome / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000150:complications; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D011278:Pregnanes / Q000652:urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D011278:Pregnanes; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone